Haloperidol

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Neuroleptic. Dopamine receptor antagonist. Standard preparation in butyrophenone active substances with good antipsychotic and distinct antiemetic effect.

IndicationThis section has been translated automatically.

  • As an antiemetic during various chemotherapies ( off-label use)
  • Acute psychotic syndromes with delusions, hallucinations, thinking disorders and ego disorders; catatonic syndromes; delirious and other exogenous psychotic syndromes.
  • Chronically progressing endogenous and exogenous psychoses (for symptom suppression and recurrence prophylaxis).
  • Psychomotoric states of arousal.

Dosage and method of useThis section has been translated automatically.

As antiemetic: 1-2 mg p.o. every 8-12 hours

Undesirable effectsThis section has been translated automatically.

When used as an antiemetic, side effects are rare. In long-term psychiatric therapy with psychiatric dosage: gynecomastia, Schwartz-Bartter syndrome, leg and pelvic vein thrombosis, peripheral and facial edema, hyponatremia, priapism, erectile dysfunction.

PreparationsThis section has been translated automatically.

Haldol

Authors

Last updated on: 29.10.2020